Zogenix (ZGNX) Zohydro ER Fails to Win FDA Panel Backing

December 7, 2012 4:38 PM EST Send to a Friend
Zogenix (Nasdaq: ZGNX) Zohydro ER fails to win FDA panel backing.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Corporate News, FDA, Trading Halts

Add Your Comment